Your search returned 3 results.

Results
	1.	Single-Dose Pharmacokinetics of Oral Cannabidiol Following Administration of PTL101: A New Formulation Based on Gelatin Matrix Pellets Technology. [electronic resource] by Atsmon, Jacob Heffetz, Daphna Deutsch, Lisa Deutsch, Frederic Sacks, Hagit Producer: 20191008 In: Clinical pharmacology in drug development vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	PTL401, a New Formulation Based on Pro-Nano Dispersion Technology, Improves Oral Cannabinoids Bioavailability in Healthy Volunteers. [electronic resource] by Atsmon, Jacob Cherniakov, Irina Izgelov, Dvora Hoffman, Amnon Domb, Abraham J Deutsch, Lisa Deutsch, Frederic Heffetz, Daphna Sacks, Hagit Producer: 20190408 In: Journal of pharmaceutical sciences vol. 107 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	The safety, tolerability, and effectiveness of PTL-101, an oral cannabidiol formulation, in pediatric intractable epilepsy: A phase II, open-label, single-center study. [electronic resource] by Mitelpunkt, Alexis Kramer, Uri Hausman Kedem, Moran Zilbershot Fink, Efrat Orbach, Rotem Chernuha, Veronika Fattal-Valevski, Aviva Deutsch, Lisa Heffetz, Daphna Sacks, Hagit Producer: 20200708 In: Epilepsy & behavior : E&B vol. 98 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)